PO Box 420, Kumeu, Auckland, New Zealand
[email protected]  |  0508-MEDICAL

Ordering and compliance portal:


  • Twitter
  • LinkedIn

© 2019 Zeacann Limited. All images © Zeacann unless otherwise indicated. 


Zeacann is patient-focused, and will operate to the highest standards of safety and assurance. Our partnership with Auckland University of Technology means we are uniquely positioned to develop novel formulations and delivery systems, bringing new products to market in line with patient needs. Coming from New Zealand, Zeacann's products will naturally have a "Clean Green " image internationally, with cannabis grown from hydrocarbon-free, fully renewable sources.

Zeacann will produce a range of Cannabis-Based Products, using sustainable methods and following operating procedures that are designed to produce standardised levels of Active Pharmaceutical Ingredients (API), such as THC and CBD. These will include:

  • Standardised herbal blends for vaporization

  • Oils, extractions and concentrates

  • Topical balms, lotions and patches for dermal absorption

  • Tablets and capsules for gastro absorption

  • Mouth sprays, lozenges, gums and sublingual absorption 

Zeacann’s first line of products is to be Satinol®, to be formulated as a Balanced Oil, 20:1 CBD drops, and 50:1 CBD capsules. Representation of how Satinol® may look are below. Zeacann has an ambitious plan to research and develop further brands and dose delivery formats to better meet the needs of patients and health practitioners in New Zealand and globally.

Show More
Show More

Zeacann will develop multiple retail brands to target different markets, uses, and price points, as well as supply unbranded semi-processed cannabis or refined ingredients.